Stable expression and characterization of the human brain potassium channel Kv2.1: Blockade by antipsychotic agents

Brain Research

Volumn 761, Issue 1, 1997, Pages 42-50

  Wible, Barbara ^b   Murawsky, Michael K ^a   Crumb Jr , William J ^c   Rampe, David ^a  

^a SANOFI   (France)

^b Rammelkamp Center   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic agent; Fluspirilene; Human; Kv2.1; Potassium channel

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; FLUSPIRILENE; NEUROLEPTIC AGENT; PIMOZIDE; POTASSIUM CHANNEL; TRIFLUOPERAZINE; TRIFLUPERIDOL;

ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN INDUCTION; PSYCHOSIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; CLONING, MOLECULAR; FEMALE; FLUSPIRILENE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; ION CHANNEL GATING; MOLECULAR SEQUENCE DATA; MYOCARDIUM; OOCYTES; PATCH-CLAMP TECHNIQUES; PIMOZIDE; POLYMERASE CHAIN REACTION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RNA, MESSENGER; TRIFLUOPERAZINE; TRIFLUPERIDOL; TUMOR CELLS, CULTURED; XENOPUS;

EID: 0030871690     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00315-6     Document Type: Article

References (20)

1. Albrecht B., Lorra C., Stocker M., Pongs O. Cloning and characterization of a human delayed rectifier potassium channel gene. Recept. Channels. 1:1993;99-110.
2. Dixon J.E., MacKinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ. Res. 75:1994;252-260.
3. + channel mRNAs from different subfamilies. J. Neurosci. 12:1992;538-548.
4. + channel current. Circ. Res. 73:1993;210-216.
5. Frech G.C., VanDongen A.M.J., Schuster G., Brown A.M., Joho R.J. A novel potassium channel with delayed rectifier properties isolated from rat brain by expression cloning. Nature. 340:1989;642-645.
6. Gould R.J., Murphy K.M.M., Reynolds I.J., Snyder S.H. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. USA. 80:1983;5122-5125.
7. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved path clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
8. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:1989;51-59.
9. Ikeda S.R., Soler F., Zühlke R.D., Joho R.H., Lewis D.L. Heterologous expression of the human potassium channel Kv2.1 in clonal mammalian cells by direct cytoplasmic microinjection of cRNA. Pflügers Arch. 422:1992;201-203.
10. + channel functions. Annu. Rev. Physiol. 54:1992;537-555.
11. King V.F., Garcia M.L., Shevell J.L., Slaughter R.S., Kaczorowski G.J. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type-calcium channel. J. Biol. Chem. 264:1989;5633-5641.
12. Klöckner V., Isenberg G. Calmodulin antagonists depress calcium and potassium currents in ventricular and vascular myocytes. Am. J. Physiol. 253:1987;H1601-H1611.
13. + current in human ventricular myocytes. Circ. Res. 78:1996;689-696.
14. + current in rat phaeochromocytoma cells. Br. J. Pharmacol. 116:1995;2603-2610.
15. Pongs O. Molecular biology of voltage-dependent potassium channels. Physiol. Rev. 72(Suppl. 4):1992;69-88.
16. + channel cloned from human heart. Mol. Pharmacol. 44:1993;642-648.
17. Roberds S.L., Tamkun M.M. Cloning and tissue-specific expression of five voltage-gated potassium channel cDNAs expressed in rat heart. Proc. Natl. Acad. Sci. USA. 88:1991;1798-1802.
18. Sah D.W.Y., Bean B.P. Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol. Pharmacol. 45:1994;84-92.
19. + channels. Science. 264:1994;844-847.
20. 2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines. Med. Res. Rev. 9:1989;123-180.